Bharat Biotech has submitted Phase III trial data for the Covaxin coronavirus vaccine to the DCGI (Drug Controller General of India), whose SEC (subject expert committee) is expected to meet later...
source https://www.ndtv.com/india-news/covaxin-phase-3-trial-data-bharat-biotech-submits-phase-3-trial-data-expert-committee-to-meet-today-2469383
source https://www.ndtv.com/india-news/covaxin-phase-3-trial-data-bharat-biotech-submits-phase-3-trial-data-expert-committee-to-meet-today-2469383
Comments
Post a Comment